Series: Gamechangers
Fixing trial design for the diabetic foot
Professor Andrew Boulton recounts problems of the past and reflects on publications that established design standards...
Professor Andrew Boulton recounts problems of the past and reflects on publications that established design standards...
Cutting-edge education for healthcare professionals working in all aspects of diabetes, all over the world. New modules added regularly, developed by world-class experts in diabetes research and care. For registered health professionals only.
This course provides an introduction to the 2024 EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease.
This course provides an introduction to 2024 consensus report on managing hyperglycaemic crises in adults with diabetes.
Professor Andrew Boulton recounts problems of the past and reflects on publications that established design standards...
Type 2 diabetes is now increasingly common in children, adolescents, and young adults — and appears to follow a...
The safety of CGM devices cannot currently be guaranteed for people in the European Union, warn Prof. Tadej Battelino...
Harmonising recommendations on the management of hyperglycaemic crises
One focus topic. Four top global experts. Different angels for your clinical practice.
Leading diabetes experts. An eye-level discussion. Decoding exciting research and clinical initiatives.
World-leading experts share their insights from the latest research in a particular area of diabetes.
A post-hoc MRI substudy of the SURPASS-3 trial suggests that tirzepatide may improve muscle fat content in people with type 2 diabetes undergoing substantial weight loss.
One patient’s response to a diet opened Professor Mikael Ryden’s eyes to the difficulties of generalised recommendati...
